Highly cytotoxic natural killer cells are associated with poor prognosis in patients with cutaneous T-cell lymphoma

• Bethany Mundy-Bosse,
• Nathan Denlinger,
• Eric McLaughlin,
• Nitin Chakravarti,
• Susan Hwang,
• Li Chen,
• Hsiaoyin Charlene Mao,
• David Kline,
• Youssef Youssef,
• Rebecca Kohnken,
• Dean Anthony Lee,
• Gerard Lozanski,
• Aharon G. Freud,
• Pierluigi Porcu,
• Basem William,
• Michael A. Caligiuri,
• Anjali Mishra

Affiliations

Bethany Mundy-Bosse

Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH;; The Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH;; Bethany Mundy-Bosse, Comprehensive Cancer Center, Division of Hematology, Department of Internal Medicine, The Ohio State University, 882 Biomedical Research Tower, 460 W. 12th Ave, Columbus, OH 43210;

Nathan Denlinger

Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH;

Eric McLaughlin

Department of Biomedical Informatics, The Ohio State University, Columbus, OH;

Nitin Chakravarti

Nationwide Children's Hospital, The Ohio State University, Columbus, OH;

Susan Hwang

Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH;

Li Chen

The Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH;

Hsiaoyin Charlene Mao

The Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH;

David Kline

Department of Biomedical Informatics, The Ohio State University, Columbus, OH;

Youssef Youssef

Department of Pathology, The Ohio State University, Columbus, OH;

Rebecca Kohnken

Department of Veterinary Biosciences, The Ohio State University, Columbus, OH;

Dean Anthony Lee

Nationwide Children's Hospital, The Ohio State University, Columbus, OH;

Gerard Lozanski

Department of Pathology, The Ohio State University, Columbus, OH;

Aharon G. Freud

The Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH;; Department of Pathology, The Ohio State University, Columbus, OH;

Pierluigi Porcu

Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA;

Basem William

Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH;

Michael A. Caligiuri

Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH;; The Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH;

Anjali Mishra

The Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH;; Division of Dermatology, Department of Internal Medicine, The Ohio State University, Columbus, OH; Anjali Mishra, Comprehensive Cancer Center, Division of Dermatology, Department of Internal Medicine, The Ohio State University, 886 Biomedical Research Tower, 460 W. 12th Ave, Columbus, OH 43210